Announcement on Voluntary Information Disclosure of Wholly-owned Subsidiary's Drug Passing Consistency Evaluation for Generic Drugs

About this update from Shanghai Shyndec Pharmaceutical Co., Ltd. Class A

Announcement on Voluntary Information Disclosure of Wholly-owned Subsidiary's Drug Passing Consistency Evaluation for Generic Drugs The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Shyndec Pharmaceutical Co., Ltd. Class A